drug

copanlisib hydrochloride

Marketedupdated 2mo ago

by Bayer HealthCare Pharmaceuticals Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 22, 2029

~3.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Mar 29, 2032compositionUS 10383876
Mar 29, 2032method-of-use (U-2124)US 9636344
Oct 22, 2029compositionUS RE468563.3y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 58m ago

Found something off?